Improving patient access to gene and cell therapies for rare diseases in Europe.

In this report, EURODIS reviews the challenges and proposals for improving patient access to advanced therapeutic medicinal products in England. 
 

Last updated:

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts
-
Your feedback helps us keep EuroGCT online. Please can you take 30 seconds to answer these quick questions?
How would you rate your experience using EuroGCT.org today?
Poor
Great
Is the information on this website understandable?
Not at all understandable
Very understandable
Is the information on this website useful?
Not at all useful
Very useful
Is the website easy to use and navigate?
Not at all easy
Very easy
Why are you interested in gene and cell therapies and research?
CAPTCHA